-
The outpatient substance use disorder (SUD) industry has evolved from a landscape of mom-and-pop businesses to a field dominated by sophisticated providers seeking to provide quality care. While the SUD industry has matured over the last decade, it still faces significant roadblocks like stigma surrounding medication-assisted treatment (MAT) and fragmentation. The splintered SUD market offers […]
-
GEHA Ventures Invests in Addiction Recovery Startup You Are Accountable
By Chris Larson| January 17, 2024GEHA Ventures made its first investment in You Are Accountable to enable better access to substance use disorder treatment care. New York City-based You Are Accountable raised $2 million late last year in a funding round led by GEHA Ventures. The recently formed venture capital investment entity invested in the startup because Accountable’s focus is […]
-
Clinicians may not be fully aware of poppy seed tea, a novel opioid made using easily obtained unwashed poppy seeds. Poppy seed tea has similar risks to other opioids, including the potential for death, according to research led by Scott Weiner, Bicycle Health’s director of research and emergency physician. Patients who seek treatment for poppy […]
-
Medicaid Making Major Progress in SUD, But Critical Coverage Gaps Remain
By Matthew Blake| January 16, 2024Stephanie Strong founded Boulder Care in 2017 with an ambitious goal: build a profitable substance use disorder (SUD) treatment business that would also accept Medicaid patients, many caught up in the opioid epidemic. Strong’s timing proved auspicious. Over a year later, a new federal law came into effect requiring states to cover federally approved opioid […]
-
Proposed Law Would Increase Methadone Access for 43.5M Americans
By Chris Larson| January 10, 2024New research lays out the hypothetical impact of the Modernizing Opioid Treatment Access Act (MOTAA), a bill in Congress that would loosen methadone prescribing regulations. The bill has faced backlash from many organizations in the behavioral health space. Data analysis by researchers at the University of Pittsburgh, the University of Chicago, the University of Gothenburg […]
-
Medications like methadone and buprenorphine have become the gold standard for treating opioid use disorder (OUD). But many people with OUD still receive abstinence-based treatment or no treatment at all for the chronic disorder. And people with OUD who receive abstinence-only treatment are more likely to die than people who receive no treatment at all, […]
-
At 11 years old, Tom Rodman told his parents he would one day own a summer home on Lake Megunticook just outside Camden, Maine. After four decades working on Wall Street, he not only fulfilled that dream but also established a luxury residential treatment program for drug, alcohol and co-occurring mental health issues in Camden […]
-
Despite an “urgent” need for Medicare beneficiaries to receive treatment for opioid use disorder (OUD), a low percentage receive potentially life-saving medication-assisted treatment (MAT) for the condition. Approximately 52,000 Medicare enrollees experienced an opioid overdose in 2022, according to a report from the Office of Inspector General (OIG). However, only 18% of Medicare patients with […]
-
For years, University of Michigan alumni Robin McIntosh and Lisa McLaughlin, both in long-term recovery from a substance use disorder (SUD), observed the challenges in America’s broken addiction treatment system. Then, in 2015, fueled by a desire for a low-stigma, accessible solution, they founded Workit Health, a virtual SUD treatment provider. “Going through the experience […]
-
How Fentanyl Has Changed Opioid Use Disorder Treatment
By Matthew Blake| January 2, 2024The number of U.S. fatal drug overdoses has more than doubled in the past eight years, with about 110,000 such deaths in 2022, according to the National Institutes of Health. The leading cause of death, by far, is fentanyl, which has gone from prescription pain reliever to a synthetic opioid furtively smuggled into the country, […]